Mature human erythrocytes possess the enzymes necessary to catabolize glucose to CO2 via pentose phosphate pathway or to lactic acid via the Embden-Meyerhof pathway. These cells are deficient in certain enzymes of the tricarboxylic acid cycle. In the non-nucleated red cells, the oxidative reactions of pentose phosphate pathway appear to be the sole mechanism for glucose conversion to CO2 and for the generation of TPNH (2, 3). Several investigators have suggested that a major factor in the control of the rate of glucose catabolism via the pentose phosphate pathway is the metabolic demand for TPNH (4-6). It has been demonstrated that addition of dyes capable of acting as electron acceptors from TPNH (i.e., methylene blue, phenazine methosulphate, pyocyanin) increases the rate of activity of this pathway in erythrocytes, liver slices and mammary glands (7-9). Stimulation of the pentose phosphate pathway by pyruvate in bovine corneal epithelium, by insulin in rat mammary tissue, and by ammonium salts in yeasts has been ascribed to supply of substrates requiring TPNH for their metabolism or to stimulation of enzyme systems which utilize TPNH (8, (10) (11) (12) .
Mature human erythrocytes possess the enzymes necessary to catabolize glucose to CO2 via pentose phosphate pathway or to lactic acid via the Embden-Meyerhof pathway. These cells are deficient in certain enzymes of the tricarboxylic acid cycle. In the non-nucleated red cells, the oxidative reactions of pentose phosphate pathway appear to be the sole mechanism for glucose conversion to CO2 and for the generation of TPNH (2, 3) . Several investigators have suggested that a major factor in the control of the rate of glucose catabolism via the pentose phosphate pathway is the metabolic demand for TPNH (4) (5) (6) . It has been demonstrated that addition of dyes capable of acting as electron acceptors from TPNH (i.e., methylene blue, phenazine methosulphate, pyocyanin) increases the rate of activity of this pathway in erythrocytes, liver slices and mammary glands (7) (8) (9) . Stimulation of the pentose phosphate pathway by pyruvate in bovine corneal epithelium, by insulin in rat mammary tissue, and by ammonium salts in yeasts has been ascribed to supply of substrates requiring TPNH for their metabolism or to stimulation of enzyme systems which utilize TPNH (8, (10) (11) (12) .
Among the systems requiring TPNH is that involved in the maintenance of glutathione in the reduced state (13) . It has been demonstrated that human erythrocytes deficient in glucose-6-phosphate dehydrogenase (G6PD) are unable to maintain their level of reduced glutathione upon incubation with a variety of agents, such as acetylphenylhydrazine, primaquine, ascorbic acid, alpha naphthol, nitrofurantoin, cysteine and fava * This work was supported in part by Grants CY 2332 and RG 7368 of the United States Public Health Service. A preliminary report of a portion of these data has appeared in abstract form (1) .
t Visiting Scholar in Medicine. Present address: Government Hospital, Tel Hashomer, Israel. bean extract (14) (15) (16) (17) (18) (19) . This finding suggests that such substances might produce a relative insufficiency in the supply of TPNH either by inhibiting reactions in which TPNH is generated or by leading to an increase in the requirement for this coenzyme which exceeds the maximal capacity of cells deficient in G6PD. It is possible to distinguish between these mechanisms by determining whether these substances inhibit or stimulate the rate of oxidation of glucose by the reactions of the pentose phosphate pathway.
In this investigation a study has been made of the effect of the physiological substancescysteine, ascorbic acid and pyruvate-and of agents which can cause hemolytic anemia-acetylphenylhydrazine, nitrofurantoin, a-and-3-naphthol, primaquine and fava bean extract-on the rate of glucose oxidation via the pentose phosphate pathway by red cells. Observations have been made with erythrocytes from normal subjects and from persons with a genetically determined deficiency of G6PD. It has been found that these substances increase the oxidation rate of glucose carbon atom 1 to CO2 by red cells, but not the rate of glucose conversion to lactic acid. The stimulatory effect of these substances is much greater with erythrocytes with normal levels of G6PD than with cells from persons with a marked deficiency of this enzyme. The increased rate of glucose oxidation caused by these compounds is not attributable to a direct action on G6PD. Rather, it was found that certain of these substances oxidize TPNH in the presence of diaphorase.
METHODS
Preparation of erythrocytes. Human venous blood, collected in siliconized tubes containing heparin, was mixed with an equal volume of 3 per cent dextran (Larco, grade HH, mol wt ca. 225,000) and 3 per cent glucose in 0.15 M sodium chloride, for separation of 914 erythrocytes from leukocytes and platelets by a method described in detail elsewhere (20) . The erythrocytes were washed 3 times with 20 vol of cold 0.15 M sodium chloride solution and resuspended in Krebs-Ringer phosphate buffer, pH 7.4 (21) , to a cell concentration of about 4 X 108 per mm3. This erythrocyte suspension was contaminated with not more than 500 leukocytes per mm3 and 10,000 platelets per mm3.
Hemolysates, when employed, were prepared by lysis of 1 vol of washed packed erythrocytes with 4 vol of cold distilled water.
Isotope experiments. Two ml of the erythrocyte suspension in Krebs-Ringer phosphate buffer was placed in Warburg type flasks equipped with two side-arms. Glucose labeled in positions 1, 2 or 6 with C14 and nonlabeled glucose were placed in a side-arm together with additional substances as indicated in the tables. The final volume was made to 3 ml with Krebs-Ringer phosphate buffer. After 10 minutes' equilibration with an appropriate gas, the contents of the side-arm was tipped into the main compartment and incubation carried out at 370 C for 2 hours. At the end of this period of incubation, 1.0 ml 50 per cent trichloroacetic acid was introduced into the previously used side-arm through the gas vent of the stopper and 0.2 ml hyamine hydroxide and 0.2 ml toluene (21) were placed in the second sidearm. The contents of the side-arm containing the solution of acid was then tipped into the main compartment. Quantitative diffusion of released C1402 into the hyamine hydroxide mixture was achieved by shaking the flasks at 37°C for 1 hour. The hyamine-toluene mixture was quantitatively transferred into bottles containing 1.0 ml of absolute ethanol and 5.0 ml of 0.3 per cent 2,5-diphenyloxazole and 0.03 per cent 2,2'-p-phenylene-bis-(5-phenyloxazole) in toluene. The assay of radioactivity was performed in a liquid scintillation counter with an efficiency of 60 per cent and a background of 30 cpm (22) .
Lactic acid determinations were performed by an enzymatic procedure (23) . An aliquot of the trichloroacetic acid extract from the incubation mixtures was centrifuged and the supernatant fluid recovered and adjusted to pH 10 .0 with 1.0 N NaOH. Assay mixtures were set up in cuvets as follows: 2 ml glycine-NaOH buffer, 0.2 M, pH 10.5; 0.2 ml DPN, 1.5 X 10-M; 0.2 ml semicarbazide HCl, 1.0 M (adjusted to pH 10.5 with NaOH); 0.4 ml water and 0.2 ml of the test solution. The optical density at 340 mu of each assay mixture was determined, and 0.050 ml lactic acid dehydrogenase (twice recrystallized, Nutritional Biochemicals Corp.) was added and the change in optical density at 340 m/u was followed until no further increase was observed. As standards, solutions of lithium lactate of known concentration were assayed with each set of determinations. In preliminary experiments it was established that cysteine, ascorbic acid, acetylphenylhydrazine, nitrofurantoin, a-naphthol and primaquine in the concentrations used in these studies did not interfere with the determination of lactic acid.
Glucose was estimated in barium hydroxide filtrates (24) by the 0-amino-diphenyl method of Timell, Glaudemans and Currie (25) . This procedure was chosen because none of the compounds studied, with the exception of acetylphenylhydrazine, interfered with the color reaction. Glucose could not be estimated in the presence of acetylphenylhydrazine by this procedure or by the anthrone method (26) , by the iodometric titration method of Hagedorn-Jensen (27) or by an enzymatic procedure using "Glucostat" reagents of Worthington Biochemical Corporation (28) .
G6PD and 6-phosphogluconic dehydrogenase activities were assayed spectrophotometrically (29, 30) . A unit of enzyme activity is defined as the amount of enzyme required to give an increase in optical density of 0.001 per minute at 340 m/u (31) . Erythrocytes from normal subjects assayed by this method had an activity of glucose-6-phosphate dehydrogenase of 10,000 to 20,000 U per g hemoglobin, while those from subjects with a fully expressed hereditary deficiency of this enzyme, 500 to 4,000 U per g hemoglobin.
Materials. Erythrocyte G6PD was purified from normal human erythrocytes by a method described in detail elsewhere (32) . Spinach TPNH diaphorase was prepared according to the method of Avron and Jagendorf (33) . An extract of fava bean was prepared by the method of Walker and Bowman (18) . G6PD partially purified from yeast and a preparation of diaphorase prepared from Clostridiun kluyveri were purchased from Sigma Chemical Corp. 
RESULTS
Stimulation of glucose oxidation to CO, Incubation of normal erythrocytes with cysteine, ascorbic acid, acetylphenylhydrazine, primaquine, nitrofurantoin, a-or /3-naphthol is associated with a 3-to 18-fold increase in the rate of C140 formation from glucose-i-C14 (Table I) . A consistently smaller increase in the rate of C140. formation is observed upon incubation of G6PD-deficient red cells under the same conditions. In the absence of added compounds, the rate of glucose oxidation to C140 is similar in normal and G6PD-deficient cells.
The increased rate of C1402 formation in the presence of these compounds is not caused by an action of these agents directly on glucose. This is indicated by the observation that when glucose-1-C14 is incubated with these compounds without added erythrocytes or with boiled suspensions of erythrocytes no C140, is formed.
The increase in the rate of oxidation of glucose to C140. in the presence of these substances involves glucose-6-phosphate (G6P) which is re- * Ascorbic acid and cysteine were added as neutralized solutions in Krebs-Ringer phosphate buffer. The other compounds were added as dry powders. Final glucose concentration, 1 X 10-2 M; amount of glucose-i-C'4 added, 0.6 ,uc/ flask; erythrocytes added, 6.9 to 9.0 X 109 flask; gas phase, 100% oxygen; incubation time, 2 hours.
t Normal subjects had red cell G6PD activities between 10,000 and 20,000 U/g hemoglobin. Each compound was assayed with erythrocytes of one mutant Caucasian female of Spanish extraction and a number of Negro mutants. The G6PD activity in erythrocytes of all these subjects was 1,000 to 4,000 U/g hemoglobin.
I These compounds are only slightly soluble in water. Their solubility in the incubation mixture used in these experiments is not known. Accordingly, the concentrations indicated represent calculations based on the amounts added and not necessarily on the amounts actually in solution.
cycled via pentose phosphate, as well as G6P formed from glucose. Addition of the various compounds to erythrocytes incubating with glucose-2-C14 is associated with an increased rate of C140, formation (Table II) . In fact, in the presence of cysteine, ascorbic acid and acetylphenylhydrazine, the relative increase in the rate of C140, formation from glucose-2-C14 is higher than that from glucose-i-C14. When none of these compounds is added, the ratio of the rate of formation of C1409 from glucose-i-C'4 to that from glucose-2-C14 is about 6, while in the presence of these compounds it decreased to about 2. A similar decrease in this ratio is observed in the presence of methylene blue. This is in agreement with the report of Brin and Yonemoto (7) . The decrease in the ratio of the rate of C1402 formed from glucose-i-Cl4 to that from glucose-2-C14 suggests that the stimulation of the recycling of pentose phosphate to G6P is greater than the stimulation of glucose carbon 1 oxidation. The present data provide no explanation of the mechanism of this effect.
Incubation of erythrocytes with glucose-6-C14 is associated with negligible amounts of C140, formation. Addition of methylene blue, cysteine, as- * The assay mixture contained 0.5 ml 0.1 M MgC12, 0.1 ml of 2.5 X 10-3 M TPN, 0.5 ml of 0.01 M G6P, 0.005 ml G6PD purified from normal human erythrocytes or 0.050 ml hemolysate from a normal subject, 1.0 ml of a solution of the respective test substance in Krebs-Ringer phosphate buffer and water to the final volume of 3.0 ml. For 6-phosphogluconic dehydrogenase assay, 0.5 ml of 0.01 M 6-phosphogluconate was added instead of G6P. Saturated solutions of nitrofurantoin and a-naphthol were prepared by suspending 10 mg of the respective compounds in 10 ml of KrebsRinger phosphate buffer, shaking the suspensions for 10 minutes at room temperature and then centrifuging them.
t 33% Saturated solution indicates that the saturated solution of these compounds was in a threefold dilution in the final reaction mixture.
crease in the rate of C140, formation is observed in the presence of a boiled preparation. The higher rate of C1402 formation upon incubation with an unboiled extract requires further elucidation, since a small quantity of C140 was also formed from glucose-1-C14 in the absence of erythrocytes, suggesting that the extract itself contained a system capable of oxidizing glucose to CO2.
Studies of the mechanism of stimulation of glucose catabolism via the pentose phosphate pathway 1) Effect of the stimulatory compounds oni the activity of G6PD. The possibility has been investigated that the increase in the rate of glucose oxidation to C1402 caused by the various agents may be a consequence of a direct action on the activity of G6PD. No increase in the activity of preparations of this enzyme purified from erythrocytes or of the enzyme in crude hemolysates is observed upon addition of any of the compounds studied (Table VII) . In fact, a-napththol and nitrofurantoin inhibit G6PD activity, a finding similar to that previously reported by Desforges, Kalaw and Gilchrist (37) . Nitrofurantoin also inhibits 6-phosphogluconic dehydrogenase activity.
2) Effect of the stimnulatory compounds on TPNH oxidation. The following experiments were performed to determine if the compounds stimulating glucose oxidation via the pentose phosphate pathway cause a direct or enzyme-mediated oxidation of TPNH. a) TPNH was added to solutions of cysteine, ascorbic acid, acetylphenylhydrazine, a-naphthol, primaquine and nitrofurantoin buffered at pH 7.4 and the change of optical density at 340 mpu followed with time. Of these several compounds, only cysteine causes a non-enzymatic oxidation of TPNH. The rate of oxidation increases (but not by a linear relationship) with rising cysteine concentration to 1.0 x 10-2 M. Further increase in cysteine concentration is associated with a fall in the rate of TPNH oxidation.
b) The experiments indicated above were then performed with the addition of a preparation of a TPNH-specific diaphorase purified from spinach leaves or a diaphorase prepared from Cl. kluyveri which had activity with either TPNH or DPNH. (Figure 1 ). The addition of ascorbic acid, primaquine or acetylphenylhydrazine to such a mixture is not associated with a change in optical density at 340 mt. In the presence of the dia-phorase prepared from Cl. kluyveri, however, a decrease in optical density at 340 m/A is observed when ascorbic acid or primaquine, as well as nitrofurantoin or a-naphthol is added to a solution of TPNH. The change in optical density in these experiments is also linear with time and related to the concentration of the added compounds ( Figure 2 ) and to the activity of the diaphorase. The difference in the results obtained with the two diaphorase preparations has not been elucidated. In any event, it would appear that the decrease in optical density observed in the presence of these enzymes represents oxidation of TPNH and not its decomposition by these compounds because it may be largely reversed by addition of a system capable of TPN reduction. An experiment demonstrating a reversal of the oxidation of TPNH in the presence of ascorbic acid by a subsequent addition of G6P and G6PD is illustrated in Fig volumes of a saturated solution of nitrofurantoin or a-naphthol, and diaphorase with an activity of 12 U per ml, prepared from spinach (33) . The total volume is 3.0 ml and the incubation is at 240 C. Curve A, nitrofurantoin 0.100 ml, diaphorase 1.2 U; curve B, nitrofurantoin 0.25 ml, diaphorase 0.6 U; curve C, nitrofurantoin 0.25 ml, diaphorase 1.2 U; curve D, a-naphthol 1.0 ml, diaphorase 1.2 U. Control assay mixtures which contain: 1) TPNH and diaphorase, 2) TPNH and nitrofurantoin or a-naphthol, and 3) diaphorase and nitrofurantoin or ax-naphthol, show no change of optical density. Table VII) ; primaquine phosphate, 2 X 10' M; or ascorbic acid, 5.7 X 102 M. The volume is made up to 3 ml with the buffer solution. Curve A, a-naphthol, diaphorase 0.45 U; curve B, primaquine, diaphorase 0.9 U; curve C, nitrofurantoin, diaphorase 0.9 U; curve D, ascorbic acid, diaphorase 0.45 U. The control assay mixture from which diaphorase is omitted shows no change in optical density. Control assay mixtures containing only TPNH and diaphorase show a slight decrease in optical density which is related to the diaphorase concentration. This decrease in optical density is indicated on the ordinate at zero abscissa value.
state between the oxidation of TPNH by ascorbic acid and diaphorase and the reduction of TPN by G6P and G6PD. Addition of more G6PD after the plateau is reached results in shifting this equilibrium toward a higher TPNH concentration. Similar results are obtained with nitrofurantoin, a-naphthol and primaquine.
3) Preventing hemoglobin conversion to choleglobin. It has been reported that incubation of hemoglobin with ascorbic acid in the presence of oxygen results in its conversion to choleglobin, probably by a process of coupled oxidation and formation of hydrogen peroxide (38) (39) (40) (41) . Acetylphenylhydrazine and cysteine may also cause an oxidative breakdown of hemoglobin. Recently, Mills and Randall have reported purifying from red cells of rat and of cow a GSH peroxidase, which catalyzes the reduction of H202 by reduced glutathione (GSH) leading to the formation of oxidized glutathione (GSSG) (40, 42, 43 1 Formation of oxidation products of hemoglobin upon incubation of crystalline hemoglobin with GSH has also been observed by Mills and Randall, but it was prevented by addition of purified GSH peroxidase (41) . (44) The mode of action of the various compounds in stimulating the rate of glucose catabolism via the pentose phosphate pathway may differ. This is suggested by the observation that conversion of hemoglobin to carboxyhemoglobin followed by incubation in an atmosphere of nitrogen affects to a different extent the stimulatory activity of the various compounds.
It is probable that the increase in the rate of oxidation of glucose to CO2 results from a morerapid rate of reoxidation of TPNH formed in the oxidative steps of the pentose phosphate pathway. It was found that cysteine may lead to a non-enzymatic oxidation of TPNH, while nitrofurantoin, ascorbic acid, primaquine and a-naphthol may cause TPNH oxidation in the presence of a suitable diaphorase. Scott and Griffith have purified a diaphorase from human erythrocytes, which catalyzes the reduction of methemoglobin by TPNH (although at a much slower rate than by DPNH) (45) . The activity of nitrofurantoin, ascorbic acid, a-naphthol and primaquine in the presence of such a diaphorase from human erythrocytes has not yet been investigated. Such studies are necessary to determine the applicability of the present findings with plant or bacterial diaphorase in explaining the metabolic events in human erythrocytes. It is of interest that a-naphthol and nitrofurantoin inhibit G6PD activity yet increase the rate of oxidation of glucose-1-C14 to C1402. This suggests that the inhibition of the activity of the enzyme by these agents is insufficient to make the enzyme activity rather than the concentration of TPN the factor limiting the rate of glucose oxidation by erythrocytes.
A number of investigators have concluded that the reoxidation of TPNH is the limiting factor in the rate of oxidation of glucose by the pentose phosphate pathway in a variety of tissues (4) (5) (6) (7) (8) (9) (10) (11) (12) There is another aspect of this stimulation of glucose catabolism via the pentose phosphate pathway which is of possible significance. A selective decrease in the activity of G6PD occurs as red cells age in vivo (46) . Old erythrocytes, as well as cells with a genetically determined deficiency in G6PD (47) have an increased susceptibility to destruction under normal conditions and, particularly, upon exposure to a variety of agents including cysteine, acetylphenylhydrazine, nitrofurantoin, a-and 8-naphthol, primaquine and the fava bean. This has suggested that the dehydrogenase reactions of the pentose phosphate pathway play an important role in the maintenance of the integrity of the red cell (14, 46, 47) . Tt is generally presumed that this is so because these reactions provide TPNH whose reductive potential, either directly or possibly through the generation of reduced glutathione, provides protection against the damaging effects of oxidative agents (14, 17, 40-43, [48] [49] [50] [51] [52] [53] [54] . The present study suggests that one mechanism by which these substances could lead to a decreased survival time of red cells is by reoxidizing TPNH. In the cells with low levels of G6PD the capacity to generate TPNH may be inadequate to provide the necessary reductive potential to protect against the oxidative effects of these compounds. The finding that TPN or TPNH, but not GSH, could protect hemoglobin against denaturation to choleglobin in the presence of ascorbic acid suggests that the protection afforded by pyridine nucleotides need not be mediated through GSH. It has been demonstrated that TPN and TPNH, but not GSH, are important to the stability of proteins other than hemoglobin, e.g., G6PD (32, 55, 56) .
SUMMARY
The rate of oxidation of glucose-i-C'4 and of glucose-2-C'4 to C1402 by erythrocytes is stimulated by certain physiological substances such as cysteine, ascorbic acid and pyruvate, as well as by agents which can cause acute hemolytic anemias, namely, primaquine, nitrofurantoin, acetylphenylhydrazine, a-and f8-naphthol and an extract of fava bean.
This stimulation is more marked with cells with normal levels of glucose-6-phosphate dehydrogenase (G6PD) than with cells deficient in this enzyme. These compounds cause no increase in the rate of glucose utilization or in the rate of lactic acid formation.
The increased rate of catabolism of glucose via the pentose phosphate pathway caused by these agents is not a result of a direct effect on G6PD activity. Indeed, a-naphthol and nitrofurantoin inhibit G6PD activity. Evidence has been obtained to suggest that the stimulation of the pathway is caused by an increased rate of reoxidation of TPNH in the presence of these compounds. A diaphorase-mediated oxidation of TPNH by nitrofurantoin, a-naphthol, ascorbic acid and primaquine has been demonstrated. Cysteine can reoxidize TPNH even in the absence of a diaphorase. The increased rate of reoxidation of TPNH may be a factor in the mechanism by which these compounds lead to the destruction of aged red cells and erythrocytes with a genetically determined deficiency in G6PD.
